149 related articles for article (PubMed ID: 31109334)
1. Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.
Cheng S; Wu J; Li C; Li Y; Liu C; Li G; Li W; Hu S; Ying X; Zhang Y
J Transl Med; 2019 May; 17(1):164. PubMed ID: 31109334
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes involved in the regrowth of clinically non-functioning pituitary adenoma.
Cheng S; Li C; Xie W; Miao Y; Guo J; Wang J; Zhang Y
Aging (Albany NY); 2020 Feb; 12(3):2408-2427. PubMed ID: 32015217
[TBL] [Abstract][Full Text] [Related]
3. Identification of a multidimensional transcriptome signature predicting tumor regrowth of clinically non‑functioning pituitary adenoma.
Cheng S; Guo J; Zhang Y; Li Z; Li C
Int J Oncol; 2020 Sep; 57(3):804-812. PubMed ID: 32582995
[TBL] [Abstract][Full Text] [Related]
4. A two‑circRNA signature predicts tumour recurrence in clinical non‑functioning pituitary adenoma.
Guo J; Wang Z; Miao Y; Shen Y; Li M; Gong L; Wang H; He Y; Gao H; Liu Q; Li C; Zhang Y
Oncol Rep; 2019 Jan; 41(1):113-124. PubMed ID: 30542712
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of functioning and non-functioning pituitary adenomas.
Qin J; Li K; Wang X; Bao Y
Medicine (Baltimore); 2021 Apr; 100(14):e25306. PubMed ID: 33832102
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of DNA methylation and mRNA expression profiles.
Cheng S; Xie W; Miao Y; Guo J; Wang J; Li C; Zhang Y
J Transl Med; 2019 Dec; 17(1):407. PubMed ID: 31796052
[TBL] [Abstract][Full Text] [Related]
7. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up.
Øystese KA; Zucknick M; Casar-Borota O; Ringstad G; Bollerslev J
Endocrine; 2017 Jul; 57(1):35-45. PubMed ID: 28516382
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas.
Yu B; Ji N; Ma Y; Yang B; Kang P; Luo F
Cephalalgia; 2017 Apr; 37(4):348-355. PubMed ID: 27154998
[TBL] [Abstract][Full Text] [Related]
9. The clinical features, recurrence risks and surgical strategies of bone invasive pituitary adenomas.
Zhu H; Li B; Li C; Liu C; Wang X; Gui S; Zhao P; Bai J; Cao L; Zhang Y
Clin Neurol Neurosurg; 2021 Feb; 201():106455. PubMed ID: 33395618
[TBL] [Abstract][Full Text] [Related]
10. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
[TBL] [Abstract][Full Text] [Related]
11. A machine learning approach to predict early outcomes after pituitary adenoma surgery.
Hollon TC; Parikh A; Pandian B; Tarpeh J; Orringer DA; Barkan AL; McKean EL; Sullivan SE
Neurosurg Focus; 2018 Nov; 45(5):E8. PubMed ID: 30453460
[TBL] [Abstract][Full Text] [Related]
12. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.
Greenman Y; Ouaknine G; Veshchev I; Reider-Groswasser II; Segev Y; Stern N
Clin Endocrinol (Oxf); 2003 Jun; 58(6):763-9. PubMed ID: 12780754
[TBL] [Abstract][Full Text] [Related]
13. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Ki67, HMGA1, MDM2, and RB expression in nonfunctioning pituitary adenomas.
Yao X; Gao H; Li C; Wu L; Bai J; Wang J; Li Y; Zhang Y
J Neurooncol; 2017 Apr; 132(2):199-206. PubMed ID: 28255749
[TBL] [Abstract][Full Text] [Related]
15. PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age.
Trott G; Ongaratti BR; de Oliveira Silva CB; Abech GD; Haag T; Rech CGSL; Ferreira NP; da Costa Oliveira M; Pereira-Lima JFS
Ann Diagn Pathol; 2019 Aug; 41():83-89. PubMed ID: 31154064
[TBL] [Abstract][Full Text] [Related]
16. Machine-Learning Prediction of Postoperative Pituitary Hormonal Outcomes in Nonfunctioning Pituitary Adenomas: A Multicenter Study.
Fang Y; Wang H; Feng M; Zhang W; Cao L; Ding C; Chen H; Wei L; Mu S; Pei Z; Li J; Zhang H; Wang R; Wang S
Front Endocrinol (Lausanne); 2021; 12():748725. PubMed ID: 34690934
[TBL] [Abstract][Full Text] [Related]
17. MCM7 as a marker of postsurgical progression in non-functioning pituitary adenomas.
Hallén T; Olsson DS; Hammarstrand C; Örndal C; Engvall A; Ragnarsson O; Skoglund T; Johannsson G
Eur J Endocrinol; 2021 Apr; 184(4):521-531. PubMed ID: 33524001
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
19. Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.
Mukai K; Kitamura T; Tamada D; Murata M; Otsuki M; Shimomura I
Endocr J; 2016 Nov; 63(11):965-976. PubMed ID: 27534814
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
